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Abstract
Background: Pseudomonas aeruginosa, an opportunistic pathogen, is often encountered in chronic lung
diseases such as cystic fibrosis or chronic obstructive pneumonia, as well as acute settings like mechanical
ventilation acquired pneumonia or neutropenic patients. It is a major cause of mortality and morbidity in
these diseases. In lungs, P. aeruginosa settles in a biofilm mode of growth with the secretion of
exopolysaccharides in which it is encapsulated, enhancing its antibiotic resistance and contributing to the
respiratory deficiency of patients. However, bacteria must first multiply to a high density and display a
cytotoxic phenotype to avoid the host's defences. A virulence determinant implicated in this step of
infection is the type III secretion system (TTSS), allowing toxin injection directly into host cells. At the
beginning of the infection, most strains isolated from patients' lungs possess an inducible TTSS allowing
toxins injection or secretion upon in vivo or in vitro activation signals. As the infection persists most of the
bacteria permanently loose this capacity, although no mutations have been evidenced. We name "non
inducible" this phenotype. As suggested by the presence of a positive feedback circuit in the regulatory
network controlling TTSS expression, it may be due to an epigenetic switch allowing heritable phenotypic
modifications without genotype's mutations.
Results: Using the generalised logical method, we designed a minimal model of the TTSS regulatory
network that could support the epigenetic hypothesis, and studied its dynamics which helped to define a
discriminating experimental scenario sufficient to validate the epigenetic hypothesis. A mathematical
framework based on formal methods from computer science allowed a rigorous validation and
certification of parameters of this model leading to epigenetic behaviour. Then, we demonstrated that a
non inducible strain of P. aeruginosa can stably acquire the capacity to be induced by calcium depletion for
the TTSS after a short pulse of a regulatory protein. Finally, the increased cytotoxicity of a strain after this
epigenetic switch was demonstrated in vivo in an acute pulmonary infection model.
Conclusion:  These results may offer new perspectives for therapeutic strategies to prevent lethal
infections by P. aeruginosa by reverting the epigenetic inducibility of type III cytotoxicity.
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Background
Pseudomonas aeruginosa is a Gram-negative opportunistic
pathogen associated with sepsis in burned, neutropenic,
and intensive care patients as well as with severe chronic
lung injury in cystic fibrosis and chronic obstrusive pneu-
monia disease[1]. Cytotoxic P. aeruginosa inject toxins
from their cytoplasm into eukaryotic target cells through
a protein secretory apparatus, the type III secretion system
(TTSS)[2]. Activation of this system (especially toxins pro-
duction and secretion) is dependant on the contact
between the bacteria and the host cells in vivo and could
be triggered by calcium depletion of the growth medium
in vitro. TTSS is encoded by three classes of genes coding
the secretion apparatus, the toxins and the regulators.
Four TTSS toxins are known in P. aeruginosa to be secreted
through the TTTS: ExoS, ExoT, ExoY and ExoU. All three
classes of TTSS genes are co-ordinately controlled by a
common transcriptional activator ExsA encoded by the
exsCEBA operon, which controls its own synthesis[3]. The
first gene of the TTSS exsD-pscBL operon encodes ExsD
which inhibits ExsA activity by forming an inactive com-
plex[4]. Fixation of ExsD to ExsA is prevented by ExsC,
encoded by the first gene of the exsCEBA operon, which
interacts with ExsD[5,6]. Finally, ExsE, encoded in the
exsCEBA operon interacts with ExsC and prevents its bind-
ing to ExsD. Upon TTSS activation by calcium depletion,
ExsE is secreted through it, thus releasing ExsC and the
inhibition of ExsA by ExsD[6,7]. This complex regulatory
network is described in figure 1A. However, numerous
strains possessing the entire set of genes required for type
III cytotoxicity cannot be induced by host contact or cal-
cium depletion unless submitted to exsA  overexpres-
sion[8,9]. These strains will be named non inducible for
type III cytotoxicity to distinguish them from truly non
cytotoxic ones, such as mutants in TTSS. It has recently
been shown that they accumulate in the lungs of cystic
fibrosis patients during long term infection.
Epigenetic phenotypic modifications arise and can be
transmitted from a cell to its progeny in the absence of any
genetic modifications. As a consequence, several pheno-
types may arise from the same genome in the same condi-
tions, which is equivalent to the existence of multiple
steady states according to physicist's terminology. Such a
phenomenon has been under investigations for example
in the lactose metabolic network of Escherichia coli since
1957 [10-12]. Since all the genes necessary for cytotoxic
secretion are present and can be activated in non induci-
ble P. aeruginosa strains, this is consistent with the hypoth-
esis that the transition from inducibility to non
inducibility of type III cytotoxicity is an epigenetic switch.
Thomas conjectured that a positive feedback circuit (com-
prising interacting elements, each of which exerts, directly
or indirectly, a positive action on itself) in a non linear
dynamical system, such as a regulatory network control-
Models of the Regulation of the TTSS Figure 1
Models of the Regulation of the TTSS. (A) The regula-
tory network of the type III secretion system. Regulators 
encoded outside of the ExsA regulon are not shown. Filled 
arrows and dashed lines represent positive or negative inter-
actions respectively, dotted lines stand for transcription and 
translation, opened arrows represent the secretion of pro-
teins. (B) The molecular sub-network drawn here only 
shows interactions involved in feedback circuits: autoregula-
tion of exsA, activation by ExsA of the operons involved in 
the cytotoxic response, and the inhibition of ExsA by ExsD. 
Induction of secretion and expression of cytotoxicity by the 
target, or by calcium depletion, is considered constant and is 
therefore not indicated. Other regulations of the exsA gene 
are not represented. (C) The minimal regulatory graph 
extracted from the molecular graph. The three variables are 
x = ExsA, y = ExsD (the ExsA inhibitor), and z = type III 
secretory apparatus and toxin secretion. The four arrows 
represent autoregulation of the exsA gene (x→x), transcrip-
tional activation of the exsD gene by protein ExsA (x→y), 
transcriptional activation of the genes involved in type III 
secretory system (x→z), and inhibition of ExsA by ExsD 
(y→x).
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ling a biological process, is a necessary condition
(although not sufficient) for the existence of multiple
steady states[13,14]. This hypothesis has now been for-
mally demonstrated[15,16]. Thus, the presence of the
positive feedback circuit in the TTSS regulatory network
where ExsA positively regulates it's own synthesis, could
lead to a bistable behaviour for the gene exsA (either on or
off) corresponding to an epigenetic switch of the TTSS
(inducible or not)[17]. However, at least two intertwined
feedback circuits control the production of ExsA: a posi-
tive feedback circuit at the transcriptional level (ExsA is
required for its own synthesis) and a negative feedback
circuit (ExsA is required for the synthesis of its inhibitor)
(Figure 1B). The existence of the positive circuit is a neces-
sary, not sufficient, condition for multistationarity and
more particularly epigenetic bistable switches[13]. Conse-
quently, one has to check if the system actually displays
multistationarity. Molecular techniques can not by them-
selves prove or refute this hypothesis. Indeed, the absence
of a mutation can be very difficult to demonstrate, since
all possible genes in which a mutation could induce such
a phenotypic change may not be known. Furthermore, the
presence of a mutation in a putatively involved gene in
inducible strains may not mean that it is the initial cause
of the phenotypic change: an epigenetic switch could be
the first event, followed by a mutation that may further
stabilize it. Mathematical analysis of the network's
dynamic is therefore necessary to determine if the epige-
netic hypothesis is coherent: this means if a reasonable
model, which exhibits two stable solutions, can be drawn.
As the parameters of the system are not known, we used
generalized logics, a method derived from a Boolean
approach[18,19].
The actual regulatory network to analyse is the one in fig-
ure 1A. However, proteins ExsC and ExsE are modulators
of protein ExsD activity, and can be omitted from the
model (Figure 1B) as far as the aim of this model is not to
describe the whole regulatory network, but only to
address the question of the possibility of an epigenetic
switch between inducibility and non inducibility of the
TTSS. Figure 1C shows the graph that models the minimal
regulatory network: vertices represent the biological enti-
ties (x = ExsA, and y = ExsD) and lines their interactions
("-" for negative action and "+" for positive action). The
output (z) is the production of the secretory devices and
toxins secretion under induction by calcium depletion,
i.e. inducibility. This graph is similar to the one worked
out for the regulation of mucoidy in the same bacte-
ria[20]. This model, a formal computer science approach,
using model checking Computation Tree Logic (CTL) and
a dedicated framework SMBioNet[21], allowed us to fully
establish the consistency of the epigenetic hypothesis for
the acquisition of a type III cytotoxicity and to propose
experimental evidences that are sufficient to prove it. We
thus could design in vivo and in vitro experiments to test it.
Results
Computer modelling
Generalised logical analysis
Logical analysis relies on a simplification of the sigmoid
curve representing the action of a transcriptional activator
as a step function, defining a threshold of concentration
above which the activation takes place[19]. In the case of
the network shown in figure 1C, x has two distinct actions
and it is very unlikely that the concentration thresholds
above which protein ExsA is active on the promoter of
gene exsD and on the promoter of its own gene are identi-
cal. Consequently, we associate two threshold values with
x and treat it as a three-level logical variable (0, 1, 2). Var-
iable y has one action only and is treated as a two-level
logical variable (0, 1). Therefore, two different graphs
must be drawn depending on which promoter is the most
sensitive to ExsA (Figure 2). For simplicity, we consider
only the two master elements, x and y.
Another aspect of the generalised logical method is that it
allows analysis of the dynamic properties of a network in
terms of the "functionality" of its constitutive feedback
circuits. The effect of a circuit does not only depend on the
mere existence of the relevant interactions, but also on
their relative strengths, which are noted as discrete param-
eters (K). For a given regulatory network, the number of
dynamics depends on the number of thresholds and
parameters[17]. In the case of the two graphs depicted in
figure 2, there are 324 different combinations of parame-
ters for each graph. Each set of parameters defines a spe-
cific temporal behaviour. Different set of values of the
parameters can lead or not to epigenetic behaviour.
The use of a formal computer science method allows to select 
parameter set that lead to a model exhibiting the hypothesised 
behaviour
Finding suitable valuations for parameters constitutes a
major issue for the modelling. We runned the whole cor-
pus of formal methods from computer science to include
the dynamical knowledge or hypotheses on the sys-
tem[21]. Our method starts by expressing the biological
hypothesis (i.e. the epigenetic behaviour) formally, as for-
mal sentences which can be manipulated automatically
by computer. Here we applied a widely used temporal
logic called Computation Tree Logic, because time plays a
central role in behavioural properties. Moreover, formal
sentences in CTL can be automatically checked against the
648 models by using a Model Checking algorithm. Tech-
nically, behaviour is represented by a transition system
(state graph), which can be automatically computed from
the regulatory network and the values of parameters.
Then, it becomes possible to extract (via the 'brut forceBMC Bioinformatics 2006, 7:272 http://www.biomedcentral.com/1471-2105/7/272
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technique') the sets of parameters, if any, which lead to a
behaviour that satisfies the CTL sentences. Model Check-
ing thereby classifies the set of possible dynamic behav-
iours into two groups: those which satisfy the property
and those which do not. This methodology is instru-
mented by the software SMBioNet [21] which, for the
given regulatory network, automatically returns all sets of
parameters which make the hypothesis coherent with the
model.
In the present case, the dynamical hypothesis (epigenetic
hypothesis) can be translated into two CTL. In the first,
the non inducible phenotype is stable in most of the bac-
teria. The sets of parameters to be considered for consist-
ency must therefore induce a behaviour where a non-
cytotoxic bacterium (z = 0) cannot subsequently become
cytotoxic, in the same conditions. This is formally
expressed in temporal logic as: (z = 0) = > always (z = 0).
In the second CTL, the cytotoxic phenotype is stable. Thus,
even in the presence of the inhibitor (y) there is a state in
which inducibility of the type III cytotoxicity (z = 1) is
activated recurrently (i.e. z is activated in a recurrent way
even if the y♦ x inhibition is functionally active). This
means that if at a given time the bacterium has acquired
the new phenotype, then later on, it will be again in the
same state. This is formally expressed in temporal logic as:
(z = 1) = > Fs (z = 1), where Fs means "in a strict future".
The epigenetic hypothesis is consistent, if and only if, at
least one set of parameters leads to a behaviour satisfying
these two formal properties. From figure 2, z = 1 requires
that x = 2. Consequently the epigenetic hypothesis means
that it is possible to make recurrent (x = 2) and the previ-
ous formulae are equivalent to [((x = 2) = > Fs(x = 2)) and
((x = 0) = > always(not(x = 2)))] as well as to [((x = 2) = >
Fs(z = 1)) and ((x = 0) = > always(z = 0))]. SMBioNet for-
mally proves that the epigenetic hypothesis is consistent
because 8 models satisfy these formulae, 2 of which are in
agreement with the known biological facts. The state
graph, for one of these 2 models, is displayed in figure 3.
Design of a discriminating experimental scenario
In addition to proving the consistency of the epigenetic
hypothesis, formal methods can establish the discriminat-
ing power of the experimental scenario. The goal is to
prove both formal sentences in vivo. The two previous for-
mulae reflect the existence of two steady states. As indi-
cated above, the first formula states that the basal level of
x is a steady state and is consequently satisfied in vivo
which is true for a non inducible strain. Thus, only the sec-
ond formula remains to be experimentally validated. The
second formal sentence ((x = 2) = > Fs (z = 1)) is always
true when x ≠ 2 because, according to the truth table, the
implication (false = > anything) is always true. Conse-
quently it is unnecessary to conduct an experiment where
x ≠ 2. Therefore any experiment must start by pushing the
concentration of x to 2 which means to pulse x to satura-
tion with an external signal. Moreover Fs(z = 1) signifies
"wait a lapse of time to allow the system to settle down
and check if the bacterium has acquired a cytotoxic phe-
notype". If the bacterium has not changed its phenotype,
then the experiment a priori fails. Consequently the sec-
ond part of the experimental scenario is rigorously suffi-
cient to check the second formal sentence. The length of
this "lapse of time" must be determined experimentally;
Underlying dynamics depend on the values of interactions thresholds and on the parameters values Figure 2
Underlying dynamics depend on the values of interactions thresholds and on the parameters values. The labels 
of the vertices indicate the sign of the interaction and its threshold. As these thresholds are almost always unknown, value 1 
means only that the corresponding threshold is the lowest one, and value 2 that it is the second lowest threshold. Two differ-
ent graphs must then be drawn depending on which promoter is more sensitive to ExsA. (A) In this case, the threshold above 
which x is active on x is higher (level 2) than that above which it is active on y (level 1). (B) Represents the reverse case. z is an 
output element whose level is determined by the value of x: low values of x will lead to negligible amounts of z, while high val-
ues of x will lead to high levels of z.
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here it stands for "as many generations later as possible".
If the bacterium has acquired an inducible phenotype,
that lasts at least several generations after the external sig-
nal has been removed, then epigenesis is proven.
This formal approach was useful to suggest in vitro and in
vivo experiments to test our hypothesis. It showed that the
two stable attractors differ only by the amount of ExsA
protein, and that, if the hypothesis is correct, no differ-
ences in the concentration of the inhibitor ExsD can lead
to a change in phenotype (Figure 3B). Thus, if a transient
increase in the amount of ExsA protein can shift the sys-
tem from a non cytotoxic to a stable cytotoxic state, the
existence of the epigenetic switch would be demonstrated.
Experimental results
An ExsA pulse allows to recover a stable type III secretory phenotype
Experiments suggested by the formal method require
pulsing ExsA by application of an external stimulus and
observing the change in phenotype (if any) and its stabil-
ity when the stimulus is removed. In order to pulse ExsA,
we added an additional exsA gene, under the control of an
inducible promoter, to a non inducible P. aeruginosa
strain PAO1. Thus, we constructed plasmid pexsAind. In
this construction, transcription of exsA is under the con-
trol of the ptac promoter repressed by the LacI protein
produced in large amounts because of the presence of the
lacIq gene[22]. Under inducing conditions (presence of
isopropyl-beta-D-thiogalactopyranoside, IPTG), tran-
scriptional repression by LacI is inhibited, permitting
over-expression of the exsA gene from the ptac promoter.
This induction is immediately released when the medium
is depleted of the inducer. The most straightforward test to
determine the resulting phenotype is the electrophoretic
detection of the type III toxins secreted in vitro after bacte-
ria have been submitted to calcium depletion.
Strain PAO1 used in this study was described as unable to
induce death of human polymorphonuclear neutrophils
through the TTSS[23], and is non inducible (does not pro-
duce type III toxins). This strain was transformed with pex-
sAind. In the absence of inducer it produced no, or very
little, toxin after 3 hours of culture in calcium-depleted
medium (Figure 4A, lane 3). Strain CHA, a cytotoxic strain
that secretes large amounts of toxins ExoS and ExoT[23],
was used as a positive control (Figure 4A, lane 1). The
presence of IPTG during the 3 h of growth (not shown) or
for a 20 min pulse before the 3 h culture (Figure 4A, lane
4) results in substantial toxin production. We observed
this epigenetic switch from a culture grown up to 6 hours
(about 7 generations), in Luria Bertani medium (LB)
without EGTA after the ExsA pulse, before the leakiness of
the construct became a drawback (Figure 4B, lane 1 vs. 3).
The secretory phenotype, under calcium depletion,
acquired by PAO1 (pexsAind) is therefore stable for about
One result from SMBioNet in accordance with the epigenetic  hypothesis of the regulatory graph Figure 3
One result from SMBioNet in accordance with the 
epigenetic hypothesis of the regulatory graph. SMBio-
Net provides a graphical interface that allows the user to 
define a regulatory graph and to edit temporal properties. 
SMBioNet exhibits all sets of parameters which satisfy the 
properties. Consistency is thus established if and only if at 
least one set of parameters is selected by SMBioNet. (A) 
Parameter table. The two first columns list all possible states 
of the network according to genes x and y. The third column 
gives the Kx, w parameters which define the expression level 
towards which x tends to evolve. Note that w represents all 
the positive regulatory effects that are active on x (including 
the lack of active negative effects). Here, w reflects the 
effects of x, if its value is higher than the activity thresholds 
indicated in the graph, and the effects of y, if its value is lower 
than the activity threshold. The fourth column similarly gives 
the Ky, w parameters which define the expression level 
towards which y tends to evolve. (B) State transition graph. 
The dynamics of the model are deduced from the values of 
the parameters via a desynchronisation algorithm[21].
y
x
(0,0) (1,0) (2,0)
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B
x y Kx Ky
0 0 Kx{y}=0 Ky{}=0
0 1 Kx{}=0 Ky{}=0
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2 1 Kx3=1 Ky4=1
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10 generations, after the pulse of ExsA production from
the additional gene on pexsAind. In contrast, a CHA ExsA-
mutant (CHA-D1) transformed with pexsAind did not
produce toxins in absence of IPTG nor after a 20 min
pulse (Figure 4A, lane 6–7). Secretion of type III toxins
from this strain was only obtained when IPTG was present
in the medium all along the calcium depletion (Figure 4A,
lane 8). This shows that induction of toxin secretion by a
20 min pulse in strain PAO1 required the presence of an
active feedback loop on exsA. Transient production of
ExsA is not able to promote inducibility in the absence of
an active exsA gene under the regulation of its own autoac-
tivated promoter. It also shows that this result was not an
artefact. Indeed, leakiness of the construct or noise, high
production of protein ExsA upon a 20 min IPTG pulse
(the exsA gene is on a high-copy-number plasmid and
under the control of a strong promoter), or even persist-
ence of some IPTG in the culture medium after 3 h of
growth cannot be responsible for toxin secretion. What-
ever the remaining production or presence of ExsA protein
Secretion profiles of various P. aeruginosa strains induced for type III secretion Figure 4
Secretion profiles of various P. aeruginosa strains induced for type III secretion. Coomassie blue-stained SDS-PAGE 
of TTSS secreted proteins. ExoS and ExoT toxins, the most abundant type III-related exoproducts[3], are indicated on the right 
side of the gel. IPTG was used at 1 mM. Under corresponding lanes are given the mean values (± SE) of the relative exsA mRNA 
production compared with the one of PAO1 (set to 1), measured by real time PCR in the same conditions. (A) Lane 1, CHA; 
lane 2, PAO1; lanes 3 and 4, PAO1 (pexsAind) without or with a 20 min IPTG pulse; lane 5, PAO1 ExsA-; lanes 6 and 7, PAO1 
ExsA- (pexsAind) without or with a 20-min IPTG pulse; lane 8, PAO1 ExsA- (pexsAind) with a 20 min IPTG pulse and with IPTG 
during the calcium depletion. (B) PAO1 (pexsAind) was pulsed or not with 1 mM IPTG during 20 min then washed with fresh 
LB. Next, bacteria were maintained in exponential phase of growth by serial dilution with fresh medium during a definite time 
before calcium depletion as indicated below the gel.
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in the bacteria after four generations without IPTG, it is
not high enough to promote toxin secretion by itself. To
confirm that TTSS inducibility observed was correlated to
ExsA expression we determined relative exsA mRNA level
using real time PCR under the same experimental condi-
tions used above. Results are indicated under correspond-
ing lanes in figures 4A and 4B. Relative expression levels
of exsA in strains CHA, PAO1 (pexsAind) none pulsed or
pulsed were respectively 14.3 ± 2.3, 2.2 ± 0.5 and 17.2 ±
7.4 times higher than in strain PAO1 (Figure 4A). In addi-
tion, after 10 generations following IPTG pulse, exsA level
in strain PAO1 (pexsAind) was still 12.6 ± 4.1 times higher
than in strain PAO1 under calcium depletion (Figure 4B).
These results can be compared to that obtained using tox-
ins secreted through the TTSS in the same experimental
conditions and show that the level of secreted toxins is
correlated to exsA expression in these conditions.
PAO1 (pexsAind) acquires an in vivo type III cytotoxicity after a 
transient increase of ExsA
A clinical correlation between type III secretory protein
phenotype and lung injury severity has previously been
shown[24,25]. Indeed, unlike the wild type strain CHA,
an exsA null mutant induces no increase of protein con-
centration in the bronchoalveolar lavage fluid (BALF) dur-
ing the infection[26]. Therefore, we examined, through an
acute pulmonary infection model, the cytotoxicity of
PAO1 carrying or not pexsAind. Strains were pulsed or not
with IPTG during 20 min, washed and then cultivated in
tryptic soy broth before infection. The injury of the alveo-
lar capillary barrier was estimated by the amount of pro-
teins recovered in the BALF (Figure 5). A bacterial
inoculum of 108 CFU/ml, strain PAO1 (pexsAind) treated
with an IPTG pulse, led to a higher quantity of proteins
(1.6 ± 0.2 g/dL) compared to the wild type strain (0.4 ±
0.03 g/dL) even if the latter was injected at a ten times
higher inoculum (1.04 ± 0.21 g/dL for PAO1 at 2.109
CFU/ml, data not shown). The non pulsed PAO1 (pex-
sAind) strain showed protein level ranging between the
pulsed and the wild type strain which was significantly
different. But this strain showed no significant difference
with the wild type strain injected at a ten times higher
inoculum. Although results obtained with the non pulsed
strain PAO1 (pexsAind) remained unclear, this experi-
ment illustrated the stable acquisition of cytotoxicity by a
transient increase of the main transcriptional regulator,
ExsA.
Discussion
Despite a functional wild-type genomic background,
some P. aeruginosa strains are unable to develop a type III
dependent cytotoxicity except with an over-expression, in
trans, of the transcriptional activator of this virulence sys-
tem, ExsA[8]. We proposed to call these strains non-
inducible for type III cytotoxicity. This observation and
the presence of a positive feedback loop regulating the
expression of exsA led us to hypothesize the possibility of
an epigenetic switch between inducibility/non inducibil-
ity of the type III dependant cytotoxicity in P. aeruginosa.
With the help of generalised logic and a formal computer
approach we designed a minimal model of P. aeruginosa
type III basic regulation under calcium depletion and
established the consistency of the hypothesis of an epige-
netic acquisition of an inducible type III cytotoxicity. This
model also showed that in this case, and in this case only,
an artificial (exogenous) transient increase in protein ExsA
would suffice to permanently switch a non inducible
strain to inducibility. Next, we engineered an exsA induci-
ble gene. With this construction, we demonstrated that a
stable acquisition of the secretory phenotype after a tran-
sient signal relies on the presence of the feedback loop of
the auto regulated exsA gene in agreement with the model.
These non inducible strains thus switched to inducibility,
also showed the acquisition of in vivo inducible type III
cytotoxicity. Since the exsA gene added in trans was under
the control of the inducible promoter, ptac, we have expe-
rienced leakiness or noise. This phenomenon, ubiquitous
in biological systems, is responsible for cell-to-cell varia-
tion in gene expression[27]. It has been shown to be the
cause of population bimodal heterogeneity, when cou-
pled with a feedback circuit responsible for bistability, for
instance in the repartition of lytic/temperate phages in the
population upon infection of E. coli by bacteriophage-λ
[28]. In some individuals in the population bearing pex-
sAind such a noise-dependant switch could be responsible
Epigenetic acquisition of in vivo type III cytotoxicity Figure 5
Epigenetic acquisition of in vivo type III cytotoxicity. 
Protein levels measured in the bronchoalveolar lavage fluid 
(BALF) in the three experimental groups: PAO1 pexsAind 
(108 CFU/ml) with 1 mM IPTG Pulse (pexsAind ITPG+) or 
not (pexsAind IPTG-), PAO1 (108 CFU/ml). Proteins levels 
are significantly different between each group. *p < 0.01, **p 
< 0.0001. Results are expressed as mean ± SE.
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for the slight activity observed with non induced
PAO1(pexsAind) strain in in vitro experiments (Figure 4B,
lane 3) and the in vivo increase of cytotoxicity of this
strain. Moreover it has been shown in vitro that metabolic
state, which is probably modified in lungs, regulates the
percentage of cells able to induce type III secretion gene
expression under inducing conditions evidencing that
only a subpopulation could induce type III gene expres-
sion under inducing conditions[29]. Although this does
not prove that this is the mechanism involved to acquire
or lose type III cytotoxicity during infection, the results
obtained  in vivo make the epigenetic hypothesis very
likely. However, this hypothesis does not necessarily
apply to the cytotoxicity of other bacteria, nor to mucoidy
in P. aeruginosa for which an epigenetic acquisition had
been proposed[20]. In each case, the hypothesis must be
tested, first by modelling then experimentally.
Conclusion
These in vitro and in vivo experiments, in accordance to the
predictions of the formal method, indicate that a stable
acquisition (or loss) of a phenotypic trait involved in the
pathogenicity of P. aeruginosa can arise from an epigenetic
switch. Direct therapeutic consequences could arise for P.
aeruginosa infections especially in cystic fibrosis. Any ther-
apy inhibiting the type III regulon would reduce the path-
ogenicity of the bacteria and the severity of the infection.
Since the inducibility of type III secretory phenotype is a
bistable phenotype, a reduction of ExsA activity below the
triggering threshold would be sufficient to impede the
positive feedback circuit leading to reversion of the type
III secretory phenotype and reduction of the pathogenic-
ity of the bacteria. To do so, we may investigate the use of
quorum sensing signals as the Rhl quorum sensing system
represses TTSS expression[30,31] or the effect of small
molecules able to block TTSS toxins secretion as shown in
Yersinia which could lead to a repression of the system due
to the absence of the secretion of the inhibitor ExsE[32].
According to the hypothesis that planctonic type III secret-
ing form of P. aeruginosa is responsible for early and inva-
sive phases of the infection [33-35], such a therapy would
improve antibiotic performance and other treatments to
eradicate the infection or limit spreading.
Methods
Bacterial strains and growth conditions
Pseudomonas aeruginosa strains used in this study were:
CHA, a cytotoxic isolate from a cystic fibrosis patient[36]
which secretes toxins under inducing condition for the
type III secretion system[23]; PAO1, a noncytotoxic strain
widely used in laboratory studies; PAO1 ExsA-, an isogenic
mutant of PAO1 unable to synthesize ExsA. PAO1 ExsA-
was obtained using a mutation method based on sacB
negative selection and cre-lox antibiotic marker recy-
cling[37]. Strains were routinely grown in Luria-Bertani
broth (LB), Tryptic Soy Broth (TSB) or plated on PIA
(Pseudomonas Isolation Agar, Difco, France). The pex-
sAind plasmid was introduced into PAO1 and its isogenic
mutant by electroporation and maintained with 300 µg of
carbenicilin/ml.
Construction of an inducible exsA gene
The exsA gene was amplified by PCR using the high fidel-
ity polymerase PfuUltra (Stratagene) with P. aeruginosa
chromosomal DNA as the template and primers EXSAS
and EXSAR (see table 1). Their 5' termini contain EcoRI
and HindIII restriction sites, respectively. PCR products
were ligated into pCR®-Blunt II-TOPO® vector (Invitro-
gen). The EcoRI-HindIII exsA fragment from this plasmid
was inserted into pTTQ18[22], digested by the same
enzymes. This inducible system was amplified from
pTTQ18exsA with the Xbaptac and KpnlacIq primers (see
table 1), carrying XbaI and KpnI restriction sites, respec-
tively, and inserted into the vector pCR®-Blunt II-TOPO®.
For the final construct, pexsAind, the XbaI-KpnI fragment
from the previous vector containing exsA was ligated into
pUCP20[38], a high-copy-number shuttle vector for P.
aeruginosa.
Table 1: PCR primers and probes used, restriction sites are in bold (6-FAM, 6-carboxyfluorescein; TAMRA, 6-
carboxytetramethylrhodamine).
Name Sequences (5'-3') Description
EXSAS CCGAATTCTTATAATATGCAAGGAG Amplification of exsA
EXSAR GGAAGCTTTCAAAAAACGTCAGTTA
Xbaptaq CGTCTAGATTGACAATTCATCGCCTCG Amplification of exsAind
KpnlacIq GGGTACCTCACTGCCCGC TTTCCAGT
RTExsA CAGCGAACGCGATGATGCC Reverse transcription of exsA
ExsAQS GAACTGACCGTCCAGGACAT Amplification and detection of exsA cDNA in RT PCR
ExsAQR CAACGCTCGACTTCACTCAA
ExsADL (6-Fam)CCTGGCGAGTTGCTTTTCGTCCGC(Tamra)
16s sens AAGCAACGCGAAGAACCTTA Amplification and detection of 16S rRNA cDNA in RT PCR
16as CACCGGCAGTCTCCTTAGAG
16sDL (6-Fam)ACGAAGGGACGCACGAG(Tamra)BMC Bioinformatics 2006, 7:272 http://www.biomedcentral.com/1471-2105/7/272
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Reverse transcription
Total RNA were extracted after calcium depletion using
HighPure RNA Extraction kit (Roche) according to the
manufacturer's instructions. Reverse transcription was
realized using the Transcriptor reverse transcriptase
(Roche) with 1,33 µg total RNA, 1 mM dNTP and 1 mM
of primer 16sas or RTExsA (Table 1). Primer and RNA
were mixed, heated for 10 min at 65°C then dNTP, buffer
and enzyme were added. cDNA were obtained after a reac-
tion conducted for 30 min at 55°C, followed by 5 min at
85°C.
Real time PCR
Real-time PCR assays with hydrolysis probes were con-
ducted on a LightCycler apparatus (Roche), using Fast-
Start DNA Master Hybridization Probe kit (Roche) by
following the manufacturer's instructions. Sequences of
exsA gene and 16s rRNA gene used has housekeeping gene
were obtained from the P. aeruginosa genome sequence
from Pseudomonas Genome Project[39]. Primers and
probes (table 1) were designed and obtained from Pro-
ligo® (France) and were used at final concentrations of
0.75 µM and 0.2 µM, respectively. Final MgCl2 concentra-
tion was adjusted to 4 mM. Volume of cDNA from reverse
transcription was 5 µl per assay. Thermal cycling condi-
tions were 10 min at 95°C, followed by 45 cycles of 10 s
at 95°C and 10 s at 58°C. Relative expression level of the
exsA gene to the 16s rRNA gene was calculated using the
Lightcycler software 4.0 for each strain and reported to
exsA relative expression of the strain PAO1. Values are the
mean (± standard error) of three experiments.
SDS PAGE
Bacteria were cultivated in LB broth overnight, diluted to
1.2 × 108cfu/ml in LB supplemented or not supplemented
with 1 mM ITPG and incubated with aeration for 20 min
at 37°C. Then, bacteria were spun down, washed twice in
LB and grown with aeration for 3 h at 37°C in the pres-
ence or absence of 1 mM IPTG in conditions of calcium
depletion: LB medium supplemented with 5 mM EGTA
and 20 mM MgCl2 (inducing conditions known to induce
secretion of type III toxins in vitro[40]). Bacterial densities
were determined by optical density measurement at 600
nm. Cultures were spun down, and proteins in the super-
natant were precipitated by perchloric acid (precipitated
volume was normalised to 9 × 108 cfu) and washed with
acetone. Proteins were separated on a 12% SDS-PAGE,
and stained with Coomassie blue. In the secretion experi-
ment with a delay between the IPTG pulse and calcium
depletion (Figure 4B), bacteria were pulsed with 1 mM
ITPG for 20 min then washed with LB. Next, they were
maintained in exponential phase of growth by serial dilu-
tion with fresh medium during a definite time before cal-
cium depletion.
Animals and infection model
Specific pathogen-free Sprague Dawley rats (n = 40) (280–
320 g), (Charles River Laboratoires France, St Germain/
l'Arbresle, France) were housed in the Lille University Ani-
mal Care Facility and allowed food and water ad lib. All
experiments were performed with approval of the Lille
Institutional Animal Care and Use Committee. P. aerugi-
nosa  strains were cultivated in Triptic Soy Broth (TSB)
broth overnight, diluted to 1.2 × 108cfu/ml in TSB supple-
mented or not supplemented with 1 mM ITPG and incu-
bated with aeration for 20 min at 37°C. Cultures were
then centrifuged, washed twice and grown with aeration
at 37°C in tryptic soy broth medium. After 3 hours, bacte-
ria were washed and resuspended in physiological serum
to reach a final concentration of 108 or 2 × 109 cfu/ml eval-
uated by spectrophotometry. Acute lung injury was pro-
duced according to the method described by Pennington
and Ehrie[41]. Under short anaesthesia, a small midline
incision was made on the neck ventral surface after swab-
bing it with ethanol. The trachea was exposed by blunt
dissection. Using a 28-gauge needle, 0.5 ml/kg of bacterial
suspension was instilled into the trachea, followed by
injection of 0.5 ml of air[42,43]. The animals were studied
24 h after instillation of the bacteria.
Bronchoalveolar lavage (BAL)
Bronchoalveolar lavage was performed by cannulating the
trachea. Lungs from each experimental group were
washed with a total of 20 ml in 5-ml aliquots of PBS with
3 mM EDTA. The returned fluid was pooled and centri-
fuged (200 g for 10 min). BAL fluid (BALF) samples were
filtered and immediately frozen at -80°C after collection.
Protein concentration in the BALF was measured with an
automated analyzer (Hitachi 917, Japan).
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